Sivik Global Healthcare’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.54M | Buy |
50,000
+10,000
| +25% | +$1.11M | 1.51% | 17 |
|
|
2025
Q1 | $4.48M | Buy |
+40,000
| New | +$4.48M | 2.42% | 22 |
|
|
2020
Q3 | – | Sell |
-50,000
| Closed | -$3.85M | – | 50 |
|
|
2020
Q2 | $3.85M | Buy |
+50,000
| New | +$3.85M | 1.27% | 36 |
|
|
2017
Q4 | – | Sell |
-80,000
| Closed | -$6.48M | – | 73 |
|
|
2017
Q3 | $6.48M | Sell |
80,000
-10,000
| -11% | -$810K | 2.21% | 21 |
|
|
2017
Q2 | $6.37M | Buy |
+90,000
| New | +$6.37M | 2.33% | 14 |
|
|
2017
Q1 | – | Sell |
-80,000
| Closed | -$5.73M | – | 61 |
|
|
2016
Q4 | $5.73M | Buy |
+80,000
| New | +$5.73M | 2.73% | 14 |
|
|
2016
Q3 | – | Sell |
-36,617
| Closed | -$3.05M | – | 54 |
|
|
2016
Q2 | $3.05M | Sell |
36,617
-28,383
| -44% | -$2.37M | 1.52% | 36 |
|
|
2016
Q1 | $5.97M | Buy |
+65,000
| New | +$5.97M | 2.64% | 10 |
|
|
2015
Q4 | – | Sell |
-55,000
| Closed | -$5.4M | – | 63 |
|
|
2015
Q3 | $5.4M | Buy |
55,000
+15,500
| +39% | +$1.52M | 2.62% | 12 |
|
|
2015
Q2 | $4.63M | Sell |
39,500
-50,500
| -56% | -$5.91M | 1.6% | 23 |
|
|
2015
Q1 | $8.83M | Buy |
90,000
+50,300
| +127% | +$4.94M | 3.01% | 2 |
|
|
2014
Q4 | $3.74M | Buy |
+39,700
| New | +$3.74M | 1.52% | 27 |
|
|
2014
Q2 | – | Sell |
-25,000
| Closed | -$1.77M | – | 72 |
|
|
2014
Q1 | $1.77M | Sell |
25,000
-20,000
| -44% | -$1.42M | 1.11% | 47 |
|
|
2013
Q4 | $3.38M | Buy |
+45,000
| New | +$3.38M | 2.4% | 11 |
|